Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. TVGN
TVGN logo

TVGN

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TVGN News

Tevogen Plans CRO Acquisition to Enhance Growth Potential

4d agoNewsfilter

TEVOGEN MEETS NASDAQ'S MINIMUM BID PRICE CRITERIA AGAIN

5d agomoomoo

TEVOGEN BIO HOLDINGS INC - BOARD IS STILL ASSESSING POSSIBLE ONE-TIME SPECIAL CASH DIVIDEND

Mar 13 2026moomoo

TEVOGEN BIO HOLDINGS - PRIMARY INVESTOR AFFIRMS PLAN TO KEEP EXISTING SHAREHOLDINGS

Mar 13 2026moomoo

TEVOGEN.AI ANNOUNCES PROGRESS IN PREDICTCELL™ BETA, SHOWCASING ENHANCED ACCURACY METRICS AND GROWING ITS PROPRIETARY AI FRAMEWORK

Mar 13 2026moomoo

BETA Technologies Reports Disappointing Q4 Results

Mar 09 2026Benzinga

Tevogen CEO Actively Evaluating Acquisition Opportunities

Mar 06 2026stocktwits

Tevogen Bio Advances Generics Acquisition Strategy

Mar 06 2026Benzinga

Marvell Technology Surges After Strong Q4 Earnings Report

Mar 06 2026Benzinga

Tevogen Considers Acquisition of Apozel Pharmaceuticals

Mar 06 2026stocktwits

Tevogen Enters Letter of Intent with Apozeal for Strategic Acquisition

Mar 05 2026Newsfilter

Tevogen Approves 1-for-50 Reverse Stock Split

Mar 04 2026seekingalpha

Tevogen Signs Letter of Intent with Global CRO

Feb 27 2026Newsfilter

Tevogen Enters Letter of Intent with Sciometrix for Potential Acquisition

Feb 26 2026Newsfilter

Tevogen Signs Letter of Intent with Sciometrix for Potential Acquisition

Feb 26 2026Newsfilter

TEVOGEN BIO HOLDINGS INC - AGREEMENT MAY TRANSFORM TEVOGEN INTO A PROFITABLE HEALTHCARE BUSINESS

Feb 26 2026moomoo